RECRUITING

Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will evaluate if a direct-to-patient, de-centralized, remote approach will improve clinical research outreach and engagement for patients with SCLC, in the context of a bio-specimen collection study. The study will also assess self-reported preferences and needs of patients with SCLC, regarding choosing and accessing novel therapies in research or standard clinical care settings and supportive gaps in this area, through an initial and 3 month follow up survey.

Official Title

A Study to Evaluate a Remote, Decentralized, Direct-to-Patient Strategy for Clinical Research Engagement of Patients With Small Cell Lung Cancer (SCLC), in the Context of a Bio-specimen Collection Study, and to Identify Patient-Reported Preferences and Needs Regarding Choosing and Accessing Novel Therapies and Supportive Gaps.

Quick Facts

Study Start:2025-05-23
Study Completion:2027-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06486428

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Men or women greater than or equal to 18 years of age at the time of consent
  2. 2. Ability to read, write and communicate in English
  3. 3. Provide voluntary consent to participate in this study, documented via a signed informed Consent Form (ICF)
  4. 4. Willing to provide clinical and medical information related to his/her cancer diagnoses to the study team as required
  5. 5. Willing to comply with the requirements of the study
  6. 6. Diagnosis of extensive stage primary SCLC or tSCLC
  1. 1. Known existence of an uncontrolled intercurrent illness including, but not limited to, psychiatric illness or social situations that would impair compliance with study requirements
  2. 2. Subjects who previously enrolled to this study

Contacts and Locations

Study Contact

Allison Harper, PharmD
CONTACT
833-333-7252
SUCCEED@alcmi.org

Principal Investigator

Christine Lovly, MD PhD
PRINCIPAL_INVESTIGATOR
Vanderbilt-Ingram Cancer Center, Nashville, TN

Study Locations (Sites)

Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232
United States

Collaborators and Investigators

Sponsor: Addario Lung Cancer Medical Institute

  • Christine Lovly, MD PhD, PRINCIPAL_INVESTIGATOR, Vanderbilt-Ingram Cancer Center, Nashville, TN

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-23
Study Completion Date2027-06

Study Record Updates

Study Start Date2025-05-23
Study Completion Date2027-06

Terms related to this study

Keywords Provided by Researchers

  • SCLC
  • Lung Cancer

Additional Relevant MeSH Terms

  • Small-cell Lung Cancer